Mitchell Glass's most recent trade in Q/C Technologies Inc. was a trade of 50,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 13, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TNF Pharma Inc | Mitchell Glass | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2026 | 50,000 | 50,000 | - | - | Employee Stock Option (Right to Buy) | |
| TNF Pharma Inc | Mitchell Glass | Director, Director, Chief Medical Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2025 | 11,420 | 12,500 | - | 0 | Common stock | |
| TNF Pharma Inc | Mitchell Glass | Director, Director, Chief Medical Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2025 | 1,080 | 1,080 | - | 0 | Common stock | |
| TNF Pharma Inc | Mitchell Glass | Director, President, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 125,000 | 125,000 | - | - | Employee Stock Option (Right to Buy) |